Therma Bright Inc. announced that the company has opened its existing and new distribution channels for its Venowave device. Each channel partner has expressed an interest in the Venowave solution and is eager to evaluate the commerciality of the Venowave device after pilot tests and doctor/patient validation. The Company has shipped pilot units to each channel partner for immediate distribution for these patient pilot tests.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.01 CAD | 0.00% | 0.00% | -60.00% |
1st Jan change | Capi. | |
---|---|---|
-60.00% | 2.31M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B | |
+26.76% | 32.03B |
- Stock Market
- Equities
- THRM Stock
- News Therma Bright Inc.
- Therma Bright Inc. Announces Venowave Pilot Tests with Existing and New Distribution Partners in the United States